QSAR studies on N-aryl derivative activity towards alzheimer's disease

Molecules

Volumn 14, Issue 4, 2009, Pages 1448-1455

  Solomon, Kamalakaran Anand ^a   Sundararajan, Srinivasan ^a   Abirami, Veluchamy ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Genetic Function Approximation; N aryl derivatives; QSAR

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR;

AGED; ALGORITHM; ALZHEIMER DISEASE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; HUMAN; METABOLISM; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINESTERASE; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; DRUG DISCOVERY; HUMANS; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 66349092808     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14041448     Document Type: Article

References (24)

1. Lahiri D.K.; Farlow, M.R. Greig, N.H.; Sambamurti, K. Current Drug Targets for Alzheimer's disease Treatment. Drug Develop. Res. 2004, 56, 267-281.
2. Cummings, J.L. Alzheimer's disease. Drug Ther. 2004, 351, 56-67.
3. Campiani, G.; Kozikowski, A.P.; Wang, S.M.; Liu, M.; Nacci, V.; Saxena, A.; Doctor, B.P. Synthesis and Anti cholinesterase Activity of Huperzine A Analogues Containing Phenol and Catechol Replacements for the Pyridone ring. Bioorg. Med. Chem. 1998, 8, 1413-1418.
4. Guevara-Salazar, J.A.; Espinoza-Fonseca, M.; Beltran, H.I. Correa-Basurto, J.; Trujillo-Ferrara, D.Q.Z.J.G. The Electronic Influence on the Active Site-Directed Inhibition of Acetylcholinesterase by N-aryl substituted Succinimides. J.Mex.Chem.Soc. 2007, 51, 173-177
5. Trujillo-Ferrara, J.; Correa-Basurto, J.; Espinosa, J.; Garcia, J. Solvent-free Synthesis of Arylamides and Arylimides, Analogues of Acetylcholine. Syn. Commu. 2005, 35, 1-7.
6. Duardo-Sanchez, A.; Patlewicz, G.; Lopez-Diaz, A. Current topics on software use in medicinal chemistry: Intellectual property, taxes, and regulatory issues. Curr. Top. Med. Chem. 2008, 8, 1666-1675.
7. Gonzalez-Diaz, H.; Vilar, S.; Santana, L.; Uriarte, E. Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices. Curr. Top. Med. Chem. 2007, 7, 1015-1029.
8. Gonzalez-Diaz, H.; Prado-Prafo, F.; Uberia, F.M. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr. Top. Med. Chem. 2008, 8, 1676-1690.
9. Caballero, J.; Fernandez, M.; Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized generic neural networks (BRGNN): Application to the prediction of the anatagonistic actitivity against human platelet thrombin receptor (PAR-1). Curr. Top. Med. Chem. 2008, 8, 1580-1605.
10. Gonzalez, M.P.; Teran, C.; Saiz-Urra, L.; Teijeria, M. Variable selection methods in QSAR: An overview. Curr. Top. Med. Chem. 2008, 8, 1606-1627.
11. Helguera, A.M.; Combes, R.D.; Gonzalez, M.P.; Cordeiro, M.N. Applications of 2D Descriptors in drug design: a DRAGON tale. Curr. Top. Med. Chem. 2008, 8, 1628-1655.
12. Vilar, S.; Cozza, G.; Moro, S. Medicinal chemistry and the molecular operating environment (MOE): Application of QSAR and molecular docking to drug discovery. Curr. Top. Med. Chem. 2008, 8, 1555-1572.
13. Liu, A.; Gunag, H.; Zhu; L.; Du, G. 3D-QSAR Analysis of a Newtype of Acetylcholinesterase inhibitors. Sci. China Life Sci. 2007, 50, 726-730.
14. Recanatini, M.; Cavalli, A.; Hansch, C.A. Comparative QSAR analysis of Acetylcholinesterase Inhibitors currently studied for the Treatment of Alzheimer's disease. Chem. Biol. Interact. 1997, 105, 199-228.
15. Shen, L.L.; Liu, G.X.; Tang, Y. Molecular docking & 3D-QSAR studies of 2-substituted 1-indanone derivatives as Acetylcholinesterase inhibitors. Acta Pharmacol. Sin. 2007, 28, 2053-2063.
16. Castilho, C.; Guido, R.V.; Andricopulo. Classical and Hologram QSAR Studies on a Series of Tacrine Derivatives as Butyrylcholinesterase Inhibitors. Lett. Drug Des. Discov. 2007, 4, 106-113.
17. Correa-Basurto, J.; Flores-Sandoval, C.; Marvin-Cruz, J.; Rojo-Dominguez, A.; Espinoza-Fonseca, L.M.; Trujillo-Ferrara, J.G. Docking and Quantum Mechanic Studies on Cholinesterase and their Inhibitors. Eur. J. Med. Chem. 2007, 42, 10-19.
18. Hahn, M.; Rogers, D. Receptor surface models. 2 application to quantitative structure-activity relationships studies. J. Med. Chem. 1995, 38, 2091-2102.
19. Hopfinger, A.J.; Kawayami, Y. QSAR analysis of a set of benzothiopyranoindazole anti-cancer analogs based upon their DNA intercalation properties as determined by molecular dynamics simulation. Anticancer Drug Des. 1992, 7, 203-217.
20. Kawakami, Y.; Inoue, A.; Kawai, T.; Wakita, M.; Sugimoto, H.; Hopfinger, A.J. The rationale for E2020 as a potent acetylcholinesterase inhibitor. Bioorgan. Med. Chem. 1996, 4, 1429-1449.
21. Jung, M.; Tak, J.; Lee, Y.; Jung, Y. Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections. Bioorg. Med. Chem. Lett. 2007,17, 1082-1090.
22. Anand V.R.; Vithal M.K. 3D-QSAR of Cyclooxgenase-2 Inhibitors by Genetic Function Approximation. Internet Electron. J. Mol. Des. 2003, 2, 242-261.
23. Cho, D.H.; Lee, S.K.; Kim, B.T.; No, K.T. Quantitative Structure-Activity Relationship (QSAR) Study of New Fluorovinyloxyacetamides Bull. Korean Chem. Soc. 2001, 22, No. 4.
24. Golbraikh, A.; Tropsha, A. Beware of q2! J. Mol. Graph. Model. 2002, 20, 269-276.